Get emailed when RIGL changes direction
Factor Model (net -0.1)
Factor Model
net -0.1
Est. Revisions
+0.7
Insider Activity
+0.0
Momentum
+0.0
Analyst Rev.
-1.0
Narrative Gap
+0.0
Analysis pending — waiting for first signal cycle.
Evidence
Fundamentals & Data ▾
Rigel Pharmaceuticals, Inc.
Healthcare · Biotechnology
Mkt Cap
$554M
P/E
1.5 fwd 6.2
Beta
1.27
52w Range
$16.05 - $52.24
Short Interest
3.7M 20.72%
Days to Cover
9.7 -2%
Technicals
downtrend
from 52w Hi
-0.9%
1w return
+4.1%
Insiders
selling
0B / 3S
EPS Estimate
$0.87
+12.5% 30d
0up / 1dn
Est. Dispersion
60%
3 analysts
Analyst Target
$51
$38 - $71
Options P/C
0.34
Insider Cluster
strong sell
0B / 5S
Fund Convergence
strong
Renaissance, Citadel, D.E. Shaw, Two Sigma
Financials
Revenue
$70M +21% YoY
FCF
$22M
Gross Margin
92%
Op Margin
33%
Momentum:
accelerating
Top Holders
Renaissance
$23M
Citadel
$10M
D.E. Shaw
$2M
Two Sigma
Recent Filings & Data
insider trade
30
net selling
· $569,619 sold
12 insiders · 30 transactions (30d)
Recent transactions
RODRIGUEZ RAUL R · sell · $200,075
MOOS WALTER H · sell · $145,440
MOOS WALTER H · exercise · $96,000
RODRIGUEZ RAUL R · award
SCHORNO DEAN L · award
FUREY RAYMOND J · award
SANTOS DAVID A · award
ROJKJAER LISA · award
RODRIGUEZ RAUL R · exercise · $2,192,000
SCHORNO DEAN L · exercise · $139,786
MOOS WALTER H · award
FROHLICH MARK W · award
LAPOINTE ANTHONY GREGG · award
WASMAN JANE · award
HANNAH ALISON L. · award
ALI-JACKSON KAMIL · award
SCHORNO DEAN L · sell · $80,615
FUREY RAYMOND J · sell · $59,653
SANTOS DAVID A · sell · $83,836
RODRIGUEZ RAUL R · award
SCHORNO DEAN L · award
FUREY RAYMOND J · award
SANTOS DAVID A · award
RODRIGUEZ RAUL R · exercise · $1,926,000
MOOS WALTER H · other
LAPOINTE ANTHONY GREGG · other
WASMAN JANE · other
HANNAH ALISON L. · other
ALI-JACKSON KAMIL · other
KOTZIN BRIAN L · other
1 signals · latest 23d ago
Get alerted when RIGL changes direction
We'll email you when our AI detects a shift — reversals, insider clusters, filing red flags.